Hematology

Clinical pharmacy services in hematology can have a significant impact, and the Pharmacy Times® Hematology resource center provides clinical news and articles about the topic. Here, visitors will find information about upcoming hematology conferences and meetings, updated clinical trial listings, and other resources.

What can we help you find?
[[thumbnail_alt_text]]
A discussion on the use of BTK (Bruton’s tyrosine kinase) inhibitor monotherapy for newly diagnosed chronic lymphocytic leukemia (CLL) patients, with special consideration of the RESONATE trial regimen.
[[thumbnail_alt_text]]
The FDA has approved tazemetostat for the treatment of 2 different follicular lymphoma (FL) indications.
[[thumbnail_alt_text]]
Experts in the field of chronic lymphocytic management (CLL) consider how MRD (minimum residual disease) testing affects the use of limited duration therapy.
[[thumbnail_alt_text]]
Key opinion leaders consider the decision criteria for selecting a front-line therapy for patients with chronic lymphocytic leukemia (CLL).
[[thumbnail_alt_text]]
Mitapivat is an investigational, oral, small molecule allosteric activator of wild-type and a variety of mutated PKR enzymes that is not yet approved by the FDA.
[[thumbnail_alt_text]]
IVLBCL is a rare subtype of lymphoma that is particularly hard to diagnose due to a lack of swelling or enlargement of the lymph nodes.
[[thumbnail_alt_text]]
At the 2020 American Society of Clinical Oncology Virtual Scientific Program, researchers presented a recent study that is the largest to date analyzing CLL treatment patterns among VHA patients between 2013 and 2018.
[[thumbnail_alt_text]]
Myriad factors are involved in determining the appropriate care pathway for patients with acute myeloid leukemia.
 
[[thumbnail_alt_text]]
The importance of inpatient/outpatient (IPOP) unit induction and its role in the treatment of acute myeloid leukemia.
[[thumbnail_alt_text]]
Experts in AML discuss the impact of outpatient treatment options on the quality of life for patients and review available consolidation treatments.
[[thumbnail_alt_text]]
Experts in AML discuss the impact of outpatient treatment options on the quality of life for patients and review available consolidation treatments.
[[thumbnail_alt_text]]
Review of the pharmacist’s role in outpatient care for acute myeloid leukemia.